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Evaluation of the operational challenges 
in implementing reactive screen-and-treat 
and implications of reactive case detection 
strategies for malaria elimination in a region 
of low transmission in southern Zambia
Kelly M. Searle1,2*, Harry Hamapumbu3, Jailos Lubinda3, Timothy M. Shields1,2, Jessie Pinchoff1,2, 
Tamaki Kobayashi1,2, Jennifer C. Stevenson2,3, Daniel J. Bridges4, David A. Larsen4,5, Philip E. Thuma2,3, 
William J. Moss1,2 and for the Southern Africa International Centers of Excellence for Malaria Research
Abstract 
Background: As malaria transmission declines in many regions of sub-Saharan Africa, interventions to identify the 
asymptomatic reservoir are being deployed with the goals of improving surveillance and interrupting transmission. 
Reactive case detection strategies, in which individuals with clinical malaria are followed up at their home and house-
hold residents and neighbours are screened and treated for malaria, are increasingly used as part of malaria elimina-
tion programmes.
Methods: A reactive screen-and-treat programme was implemented by the National Malaria Control Centre in 
Southern Province, Zambia, in which individuals residing within 140 m of an index case were screened with a malaria 
rapid diagnostic test (RDT) and treated if positive. The operational challenges during the early stages of implement-
ing this reactive screen-and-treat programme in the catchment area of Macha Hospital in Southern Province, Zambia 
were assessed using rural health centre records, ground truth evaluation of community health worker performance, 
and data from serial cross-sectional surveys. The proportion of individuals infected with Plasmodium falciparum who 
were identified and treated was estimated by simulating reactive screen-and-treat and focal drug administration 
cascades.
Results: Within the 1st year of implementation, community health workers followed up 32 % of eligible index cases. 
When index cases were followed up, 66 % of residents were at home in the index households and 58 % in neighbour-
ing households. Forty-one neighbouring households of 26 index households were screened, but only 13 (32 %) were 
within the 140-m screening radius. The parasite prevalence by RDT was 22 % in index households and 5 % in neigh-
bouring households. In a simulation model with complete follow-up, 22 % of the total infected population would be 
detected with reactive screen-and-treat but 57 % with reactive focal drug administration.
Conclusions: With limited resources, coverage and diagnostic tools, reactive screen-and-treat will likely not be suf-
ficient to achieve malaria elimination in this setting. However, high coverage with reactive focal drug administration 
could be efficient at decreasing the reservoir of infection and should be considered as an alternative strategy.
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Background
Substantial reductions in the burden of malaria have 
been documented in parts of sub-Saharan Africa and 
malaria elimination goals have been proposed at regional, 
national and sub-national levels [1–3]. As areas make the 
transition from malaria control to elimination, strategies 
have been developed to target the population of chroni-
cally infected individuals who are asymptomatic yet can 
contribute to transmission [4–9]. In malaria-endemic 
areas, individuals develop clinical immunity to disease 
after repeated exposure to parasites but can remain 
infectious despite the absence of symptoms or develop 
low-grade symptoms that would not prompt them to 
seek care [10, 11]. As malaria transmission declines, the 
proportion of the total infected population comprised of 
asymptomatic, chronically infected individuals with low 
parasite densities increases [12–15]. These individuals 
constitute an asymptomatic reservoir that is less infec-
tious than symptomatic, but are capable of transmitting 
parasites in areas with competent vectors [12, 14, 15].
Several strategies have been developed to identify and 
treat asymptomatic, chronically infected individuals. 
Mass drug administration treats entire populations or 
high-risk groups based on the fact that current point-
of-care diagnostic tests are not sufficiently sensitive to 
identify individuals with low-level parasitaemia [16, 17]. 
Active case detection, in contrast, involves screening 
individuals for malaria with rapid diagnostic tests (RDTs) 
within a defined geographic area (‘hot spots’) or high-risk 
populations (‘hot pops’) at regular intervals and treating 
those who test positive. Active case detection and focal 
and mass drug administration aim to eliminate parasites 
from chronically infected individuals, thus facilitating the 
interruption of local transmission [18]. The World Health 
Organization recommends that areas with moderate to 
low malaria transmission implement active case detec-
tion as part of national malaria control and elimination 
programmes [8].
One method of active case detection involves reactive 
case detection, which leverages the underlying spatial 
and temporal clustering of malaria [19–21]. Reactive case 
detection includes reactive screen-and-treat and reac-
tive focal drug administration. For reactive screen-and-
treat, residents in the home of a symptomatic index case 
and those in neighbouring households within a specified 
distance are screened with an RDT and treated if posi-
tive [6, 22, 23]. With reactive focal drug administration, 
individuals residing within an index case household 
and potentially neighbouring households are treated 
with anti-malarials without testing [24, 25]. The advan-
tage of focal drug administration is that infected indi-
viduals are treated who may otherwise be missed with 
a low-sensitivity RDT [24, 25]. Uninfected individuals 
are also treated but may benefit from chemoprophylaxis 
[24–26].
The Government of Zambia created a stepped sequence 
of interventions to achieve malaria elimination [27–29]. 
Designated as steps A through E, these interventions 
are to be implemented in succession depending on the 
parasite prevalence and case burden at health facilities 
[28, 29]. Step D consists of training volunteer commu-
nity health workers (CHWs) to perform reactive screen-
and-treat. Step D is implemented in low-transmission 
communities in which the parasite prevalence is approxi-
mately 1 % and an average of ten or fewer malaria cases 
present to a healthcare facility per week [28]. In 2013, 
Step D activities were implemented through a phased 
roll-out in selected districts in Southern Province, Zam-
bia with the goals of improving surveillance and inter-
rupting transmission [9, 27].
When an individual seeks care at a healthcare facility 
(hospital, rural health centre or rural health post) and 
tests positive for malaria by RDT, their eligibility for 
follow-up with reactive screen-and-treat is determined. 
CHWs exclude individuals with a reported travel his-
tory as these cases are presumed to be imported. Travel 
is defined as staying overnight in a place outside their 
home district within the previous month. RDT-positive 
individuals who had not travelled are eligible for reactive 
screen-and-treat. Eligible index cases are to be followed 
up within 1 week of diagnosis. CHWs are trained to visit 
the households of eligible index cases and neighbouring 
households within 140 m of an index case, screen all res-
idents with an RDT and treat everyone who tests posi-
tive [9].
The study was conducted in Kalomo, Namwala 
and Choma Districts in Southern Province, Zambia 
where the single rainy season lasts from November 
through April, followed by a cool dry season from April 
until August and a hot dry season through Novem-
ber. Malaria transmission peaks during the rainy sea-
son [30]. This area consists of villages comprised of 
small, scattered homesteads. The primary malaria vec-
tor is Anopheles arabiensis [30, 31]. The prevalence 
of malaria declined over the past decade, from 9  % in 
2008 to less than 1  % in 2013 [32], generating interest 
in malaria elimination. Challenges faced during the 1st 
year of implementation of a reactive screen-and-treat 
programme in southern Zambia were evaluated. RDT 
availability, follow-up and coverage were assessed using 
rural health centre (RHC) records and evaluation of 
CHW performance. Additional data from serial cross-
sectional surveys were used to construct simulated 
reactive case detection cascades.
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Methods
Study population
The study population for the record review and ground 
truth survey consisted of individuals eligible for reactive 
screen-and-treat from January to June 2014 as described 
below. Results from the record review and ground truth 
evaluation were used in combination with data from 
serial cross-sectional surveys conducted in the catch-
ment area of Macha Hospital from 2008 to 2013. For 
these cross-sectional surveys, a random sample of house-
holds was selected using satellite imagery every other 
month from February 2008 to December 2013. For each 
study visit, informed consent was obtained from par-
ticipants and a questionnaire was administered to col-
lect information on demographic characteristics, recent 
malaria symptoms and treatment, health-seeking behav-
iour, and knowledge of malaria risk and prevention. A 
blood sample was collected by finger prick and tested by 
RDT (ICT Malaria P.f, ICT Diagnostics South Africa). 
Participants who tested positive were offered treatment 
with artemether–lumefantrine (Coartem®) [23, 33].
Record review of reactive screen‑and‑treat
The reactive screen-and-treat programme started in the 
study area in May 2013. During the low-transmission 
season from July to September 2014, a study team from 
Macha Research Trust visited ten RHCs in Kalomo, 
Choma and Namwala Districts and abstracted data on 
reactive screen-and-treat from January to June 2014 
(within the 1st year of step D implementation) from 20 
rural health posts (RHPs) serving the catchment areas 
of the ten RHCs. RHPs are the lowest level of stationary 
healthcare and are staffed by volunteer CHWs. The num-
ber of RDTs received by a RHP, tests performed, RDT-
positive malaria cases identified, malaria cases eligible 
for reactive screen-and-treat, and eligible malaria cases 
followed up were recorded for each month. Reported 
reasons why eligible cases were not followed up were 
documented. Since 2013, healthcare facilities used the SD 
Bioline Malaria Ag P.f (Standard Diagnostics Inc, Repub-
lic of Korea).
Ground truth evaluation of reactive screen‑and‑treat
To ground truth reactive screen-and-treat performance, 
study staff visited ten RHPs associated with seven parent 
RHCs from July to September 2014 and identified index 
cases with RDT-confirmed malaria that triggered reac-
tive screen-and-treat. Study staff then randomly selected 
26 index case households that were screened during Step 
D activities between January and June 2014 for ground 
truth evaluation. The study staff and CHW visited the 
selected index case households and neighbouring house-
holds determined to be eligible for screening by the 
CHW. The study team recorded the number of residents 
within each household, the number of residents at home 
and tested by the CHW, the number of RDT-positive 
residents, the number of residents treated for malaria, 
and the distance from the index case household to neigh-
bouring households (using a GPS-enabled device). The 
time from identification of the index case to reactive 
screen-and-treat was calculated when dates were avail-
able. Data on age and sex were collected retrospectively 
from RHP records.
Construction of simulated reactive case detection cascades
The proportion of infected individuals identified and 
treated through reactive case detection was modelled. 
First, data collected through serial cross-sectional sur-
veys were used to estimate the number of total residents 
and Plasmodium falciparum-infected residents in index 
and neighbouring households. Details of the model were 
previously described [23]. In brief, all households in the 
study area were enumerated from satellite imagery and 
data from serial cross-sectional surveys were used to pre-
dict the number of residents per non-sampled household 
and the total number of infected individuals positive for 
P. falciparum by PCR in non-sampled households based 
on an ecological risk map [23]. Second, the proportion of 
infected individuals who were symptomatic (i.e., docu-
mented tympanic temperature ≥38  °C or self-reported 
fever in previous 48  h) was estimated using data from 
the serial cross-sectional surveys and extrapolated to 
non-sampled households. Third, the proportion of symp-
tomatic, infected individuals who sought care from a 
healthcare facility during their last febrile episode was 
estimated using data from the serial cross-sectional 
surveys and extrapolated to the estimated number of 
symptomatic-infected individuals in the non-sampled 
households. Fourth, a sensitivity of 95  % was used to 
determine the proportion of symptomatic-infected indi-
viduals who would be RDT-positive upon presentation 
to a healthcare facility [34]. Fifth, data from the record 
review and ground truth evaluation were used to deter-
mine the median number of neighbouring households 
per index household that would be screened as well as 
the parasite prevalence by RDT in index and neighbour-
ing households. Sixth, the sensitivity of the RDT to detect 
asymptomatic infection was estimated to be 40  % in 
index households and 23 % in neighbouring households 
compared to PCR, based on unpublished data comparing 
RDT and PCR results in the study area. These sensitivi-
ties were used to back-calculate the estimated number of 
infected individuals in index and neighbouring house-
holds. Specifically, the inverse of RDT sensitivities for 
index (1/0.4) and neighbouring households (1/0.23) were 
multiplied by the estimated number of RDT-positive 
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individuals to estimate the total number of infected 
individuals.
This model was used to estimate the proportion 
of infected individuals identified and treated under 
observed and complete coverage with reactive screen-
and-treat. The model was also used to determine the 
proportion of infected individuals treated using reactive 
focal drug administration in the index households only. 
The sensitivity of the model under varying assumptions, 
including RDT prevalence in index and neighbouring 
households, RDT sensitivity, and the ration of symp-
tomatic to asymptomatic cases, was estimated. These 
results are presented in the Additional files 1, 2, 3.
Results
Record review of reactive screen‑and‑treat
Records reviewed at the ten RHCs indicated that 411 
malaria cases were passively identified by RDT from Jan-
uary to June 2014 at the 20 RHPs. Of these, 21 cases were 
excluded by the CHWs based on reported travel history 
and 394 were considered eligible for follow-up with reac-
tive screen-and-treat. Of those eligible, 32  % (n =  126) 
were followed up. The primary reason households were 
not followed up was insufficient RDTs.
As expected, a seasonal pattern of malaria cases was 
observed, with the number of cases increasing after 
January and peaking in April (Fig. 1). As the number of 
malaria cases increased, the proportion followed up 
decreased (Fig. 1). When RHPs were stratified by malaria 
burden (high malaria burden was defined as those with 
20 or more eligible cases per month), high-burden RHPs 
had poorer follow-up as the burden of reactive case 
detection exceeded capacity (Fig.  1). Over half of the 
RHPs (n =  11) reported at least 1 month without suffi-
cient RDTs to follow up eligible index cases, and eight of 
these RHPs reported at least 1 month without sufficient 
RDTs to perform passive case detection. Low-burden 
RHPs reported more months with insufficient RDTs than 
high-burden RHPs. The parent RHCs did not report RDT 
stock-outs, suggesting challenges in distributing RDTs 
from RHCs to RHPs.
Ground truth evaluation of reactive screen‑and‑treat
The CHW registers identified 63 neighbouring house-
holds associated with the 26 index case households as eli-
gible for reactive screen-and-treat (89 total households) 
(Table  1). Study staff collected coordinates and house-
hold demographics for all 26 index case households and 
89 % (n = 56) of the 63 neighbouring households, as no 
one was home at seven households (Fig. 2). Twenty-two 
neighbouring households were not screened by CHWs 
(35 % of 63), of which 12 (55 %) were not screened due to 
a lack of RDTs, representing 19 % of the 63 eligible house-
holds. Of the 41 neighbouring households screened by the 
CHW, only 13 (32 %) were within 140 m of an index case 
household (Table 1). Study staff identified 21 households 
within 140 m of an index household (eight more than the 
CHWs) and data were collected from 18 (86 %) of these 
households, as no one was home at three households 
(Table  1). Thus, the percentage of eligible neighbouring 
households within 140 m of an index household screened 
by the CHWs was 62 % (13 of 21) (Table 1). The median 
number of households screened per index case house-
holds was three (IQR 1, 3; minimum = 1; maximum = 8).
For the 26 index cases selected for evaluation, 705 indi-
viduals residing in 82 households were eligible for reac-
tive screen-and-treat, 261 in index households and 444 
in neighbouring households (Table 1). Overall, 428 indi-
viduals (61  %) were recorded to have been screened in 
the CHW registers. In index case households, 66 % of the 
residents were reported to be screened compared with 
58  % in neighbouring households (p =  0.04) (Table  1). 
Within the 18 neighbouring households within 140  m 
for which data were available, 100 (61 %) of 165 eligible 
individuals were screened by the CHW (Table  1). The 
parasite prevalence by RDT was 22 % among residents of 
index case households and 5 % among residents of neigh-
bouring households (Table 1).
Fig. 1 Malaria cases reported and followed up with reactive screen-and-treat by month from record review. a All RHPs, b high burden RHPs, c low 
burden RHPs
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The median time between when an index case pre-
sented to a healthcare facility and the reactive screen-
and-treat was 3  days (IQR  =  2–5.5; minimum  =  1; 
maximum  =  12). The median distance from the index 
household to the neighbouring households screened 
was 194  m (IQR  =  117–303; minimum  =  36; maxi-
mum = 530 m). Thirty-two per cent of all neighbouring 
households screened by the CHWs were within 140  m 
of the index case household, suggesting the CHWs 
had difficulty delineating the 140-m radius. Thirteen 
RDT-positive individuals were detected in index and 
neighbouring households. Only one RDT-positive indi-
vidual (7.7  %) was within 140  ms of the index case 
household. However, 92  % (n =  12) of all RDT-positive 
individuals resided within 250 m of the index household 
(Table 2).
Demographic information was collected from 449 
individuals eligible for screening by reactive screen-
and-treat, 99 from index case households and 350 from 
neighbouring households. No overall differences in 
Table 1 Ground-truth evaluation of reactive screen-and-treat: household and individual characteristics
RCD reactive case detection, CHW community health worker, RDT rapid diagnostic test
Index Neighbouring Total
Household characteristic
Indicated eligible for RCD by CHW (%) 26 (100) 63 (100) 89 (100)
Identified by study staff (%) 26 (100) 56 (89) 82 (92)
Recorded in CHW register (%) 26 (100) 41(65) 67 (75)
Within 140 m of index household (%) NA 21(33) NA
Within 140 m of index household in CHW register (%) NA 13 (21) NA
Resident characteristic
Indicated eligible for RCD by CHW in 82 households with data (%) 261 (100) 444 (100) 705 (100)
Screened and recorded in CHW register (%) 171 (66) 257 (58) 428 (61)
Within 140 m of index household (%) NA 165 (37) NA
Within 140 m of index household in CHW register (%) NA 100 (23) NA
RDT positive (% of all RDTs) 37 (22) 13 (5) 50 (12)
RDT negative (% of all RDTs) 134 (78) 244 (95) 378 (88)
Fig. 2 Index households included in the ground-truth evaluation of reactive screen-and-treat
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screening by sex were observed (49.5  % male, 50.7  % 
female, p =  0.21) or when stratified by household type 
(index: 41.6 % male, 58.4 % female, p = 0.28; neighbour-
ing: 51.3 % male, 48.7 % female, p =  0.32). Residents of 
index and neighbouring households did not differ by 
age (index: median age = 13.5 years IQR = 7–23 years; 
neighbouring: median age = 14 years IQR = 6–26 years, 
p =  0.75). However, residents who were screened were 
younger than those who were not (screened: median 
age = 13 years, IQR = 6–25 years; not screened: median 
age = 19 years, IQR = 12–31 years, p < 0.01).
Reactive case detection cascades
A flow diagram of the reactive screen-and-treat and focal 
drug administration cascade construction and estimates 
is presented in Fig.  3. The total population of the study 
area was estimated to be 32,370 individuals and the P. 
falciparum parasite prevalence by PCR was estimated 
to be 2.9 % (937 infections) [23]. Based on data from the 
serial cross-sectional surveys, 23 % (n = 214) of the 937 
PCR-positive individuals were estimated to be sympto-
matic (i.e., febrile), with 36 % (n = 76) estimated to seek 
care at a healthcare facility and thus be potentially eligi-
ble to trigger reactive screen-and-treat (Fig. 3). Using an 
RDT sensitivity of 95 % for uncomplicated malaria, 73 of 
these individuals would be identified as having malaria 
at a healthcare facility (Fig.  3) [34]. The proportions of 
RDT-positive residents in the index and neighbouring 
households were estimated based on the RDT prevalence 
observed during the record reviews (22 % in index house-
holds and 5 % in neighbouring households) to capture the 
local spatial dependence of malaria transmission (Fig. 3).
Based on the eligibility criteria in which persons with 
recent travel are excluded, 5 % of RDT-positive sympto-
matic cases were estimated to be ineligible for reactive 
screen-and-treat (Figs.  4, 5, 6, 7). Thus, 95  % (n =  69) 
of the RDT-positive index cases were estimated to be 
eligible for reactive screen-and-treat. These cases rep-
resented 7 % (69 of 937) of the total infected population 
(Figs. 4a, 5, 6, 7a). Based on estimates of household size, 
an average of five household residents would be screened 
within each of the 69 index households, yielding 345 resi-
dents, with 22 % (n = 76) estimated to be RDT positive 
(Fig.  4a). Given a 40  % sensitivity of the RDT in index 
households, 189 infected individuals (20 % of total infec-
tions) were estimated to reside within the index house-
holds (Fig.  4a) [35]. With complete follow-up, in which 
all index household residents were screened, 16  % (73 
symptomatic RDT-positive index cases and 76 RDT-posi-
tive individuals residing within the index case household) 
of all infected individuals would be detected and treated 
through reactive screen-and-treat in the index house-
holds (Fig. 4a).
When neighbouring households were included in the 
model, 270 infected individuals were estimated to reside 
in the 207 neighbouring households of the 69 index 
households (Fig.  4b), representing 29  % of all infected 
individuals. Of these infected individuals, 62 (7  % of all 
infected individuals) were estimated to be RDT-positive 
based on an RDT sensitivity of 23  %. Screening neigh-
bouring households of the index case household would 
increase the percentage of the total infected population 
detected and treated from 16 to 22 %, assuming complete 
follow-up of all eligible index cases and neighbouring 
households, and with all residents at home and willing to 
be screened (Fig. 4b).
Using the same data consisting of 69 index cases, 
189 infected individuals in index households, and 270 
infected individuals in neighbouring households, the 
effectiveness of reactive focal drug administration was 
simulated. In this analysis, the sensitivity of the RDT 
for asymptomatic infected individuals is not relevant as 
residents are treated without testing. With complete fol-
low-up of all eligible index cases, 28 % (n =  258), of all 
infected individuals would be treated through focal drug 
administration at the index household (Fig.  5a). When 
neighbouring households were included, 57 % (n = 531) 
of all infected individuals would be treated through focal 
drug administration (Fig. 5b).
These data were also used to model the proportion of 
infected individuals treated under the coverage observed 
during the RHC evaluation and ground truth surveys, in 
which follow-up of eligible index cases was only 32  %. 
In index households, 66 % of the residents were at home 
during screening and 58  % were at home in neighbour-
ing households. Under observed coverage, screening and 
Table 2 Cumulative numbers of  neighbouring households, individuals, and  RDT-positive cases by  distance from  index 
households identified through the ground-truth evaluation of reactive screen-and-treat
RDT rapid diagnostic test, CHW community health worker
140 m 250 m 300 m 350 m 400 m 450 m 500 m 550 m
Households indicated as eligible by CHW (% indicated as eligible) 21 (33) 40 (64) 47 (75) 49 (78) 55 (87) 59 (93) 62 (98) 63 (100)
Households screened by CHW (% households screened) 13 (32) 28 (68) 30 (73) 32 (78) 35 (85) 37 (90) 40 (98) 41 (100)
Residents in screened households (% residents screened) 78 (30) 182 (71) 196 (76) 214 (83) 236 (92) 239 (93) 254 (99) 257 (100)
RDT positive cases in screened households (% RDT positive cases) 1 (8) 12 (92) 12 (92) 13 (100) 13 (100) 13 (100) 13 (100) 13 (100)
Page 7 of 14Searle et al. Malar J  (2016) 15:412 
treating index case households would have detected and 
treated only 9 % of the total infected population (Fig. 6a), 
which increased to 11 % of the total infected population 
when neighbouring households were included (Fig.  6b). 
The same observed coverage was used to model focal 
drug administration. Under observed coverage, 11  % 
of all infected individuals in the population would have 
been treated (Fig.  7a), which increased to 17  % when 
neighbouring households were included (Fig. 7b).
The cascades identified key areas that impact the effec-
tiveness of reactive case detection to identify and treat 
infected individuals, including the ratio of symptomatic 
to asymptomatic infections, care-seeking behaviours and 
the RDT sensitivity (Fig. 8).
Discussion
Implementation of reactive screen-and-treat in this area 
of southern Zambia faced several operational challenges, 
as would be expected with a new programme using vol-
unteer CHWs and RDTs to expand clinical services into 
the community. Approximately one-third of eligible 
index case households resulted in reactive screen-and-
treat and coverage decreased to one-quarter among 
RHCs with a higher burden of malaria. This low coverage 
was likely due to two factors. First, the follow-up screen-
ing was logistically difficult for CHWs due to the high 
number of cases during the peak malaria season. Step 
D activities were designed to be implemented when the 
number of malaria cases is approximately ten per week. 
Despite historically low transmission in this setting, some 
RHCs reported more than 70 eligible cases per month 
during the peak transmission season. This overwhelmed 
the capacity of the CHWs to conduct reactive case detec-
tion. During peak transmission times the programme 
would benefit from having additional CHWs available, or 
perhaps consider suspending reactive case detection dur-
ing peak transmission.
The second challenge was insufficient RDTs as a con-
sequence of the high number of cases and difficulty in 
anticipating the additional quantity of RDTs needed to 
conduct reactive case detection. Over 50  % of CHWs 
reported having at least 1  month when reactive screen-
and-treat was not done due to lack of RDTs, and 40  % 
of CHWs reported at least 1 month when not even pas-
sive screening with RDTs could be performed. During 
this period, the parent RHCs did not report stock-outs 
Fig. 3 Reactive screen-and-treat flow diagram for complete coverage
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or limited RDTs, implying delays, interruptions, or fail-
ures by RHC staff in distributing sufficient RDTs to the 
CHWs during the initial stages of implementing the reac-
tive case detection programme. Following CHW training, 
a moderate stock of RDTs was provided to CHWs and 
RHC staff were notified that additional RDTs should be 
requested and released to CHWs to support Step D activ-
ities. Clearly to implement Step D, a reliable and ample 
supply of RDTs is necessary; however, the rapid seasonal 
changes in transmission makes predicting the required 
number of RDTs challenging and surge capacity may not 
be feasible. Over time, programmes should improve their 
Fig. 4 Coverage cascades of reactive screen-and-treat with complete coverage of index and neighbouring households. a Index households only, b 
index households and neighbors
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ability to predict need and maintain an adequate stock of 
RDTs at the level of the RHPs. However, the cost may be 
that RDTs are stockpiled at these facilities and, if unused, 
may expire.
When eligible index cases were followed up, three 
main challenges were identified that hindered the ability 
to identify infected individuals through reactive screen-
and-treat. First, only one-half to two-thirds of residents 
were at home at the time of screening and residents not 
at home were older than those at home. Those not at 
home included school-age children and young adults, 
the age group most commonly comprising the chroni-
cally infected reservoir that reactive case detection 
aims to identify and treat [3]. This challenge could be 
overcome. Notifications could be made to let individu-
als know when the CHW would be visiting. Households 
Fig. 5 Coverage cascades of reactive focal drug administration with complete coverage of index and neighbouring households. a index house-
holds only, b index households and neighbors
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could be revisited to attempt to access those unable to 
be at home during the first visit. Second, while theoreti-
cally simple, identifying households within 140  m (the 
distance of one-and-a-half football fields) of an index 
case was difficult for the CHWs in practice. Sixty-eight 
per cent of neighbouring households screened by CHWs 
were outside the 140-m radius. Some CHWs screened 
neighbouring households over half a km from an index 
case household. While reactive screen-and-treat pro-
grammes in other countries screen further from the 
index household, in this setting nearly all RDT-positive 
individuals were within 250  m of the index household 
[6, 22, 36]. This demonstrates not only the difficulty in 
identifying the appropriate screening radius, but also the 
Fig. 6 Coverage cascades of reactive screen-and-treat with observed coverage of index and neighbouring households. a Index households only, b 
index households and neighbors. a Index households only, b index households and neighbors
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burden of unnecessary screening given the lack of RDTs 
and logistical challenges when the case burden is high. 
Lastly, as is widely recognized, the low sensitivity of 
RDTs limits the ability to identify individuals with low-
level parasitaemia in areas approaching malaria elimi-
nation [14, 37, 38]. Even with complete follow-up, and 
with an RDT sensitivity of 40 % in index households and 
23 % in neighbouring households, only 16 % of infected 
individuals were estimated to be identified by screen-
ing all index households and 22 % of infected individu-
als by screening neighbouring households. While the 
infectiousness of individuals with low parasitaemia is 
variable, a large portion of the malaria reservoir in this 
area would be not treated. Given the poor sensitivity of 
Fig. 7 Coverage cascades of reactive focal drug administration with observed coverage of index and neighbouring households. a Index house-
holds only, b index households and neighbors
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RDTs in this low-transmission setting, and the current 
lack of more sensitive field-deployable diagnostics, reac-
tive focal drug administration may be a more efficient 
use of resources [17, 24]. With complete coverage, under 
the assumptions of the model, potentially 60  % of the 
total infected population in this setting would be treated 
through reactive focal drug administration of index and 
neighbouring households. However, complete coverage 
will be logistically difficult, and many improvements in 
follow-up strategies, including gauging neighbouring 
household distances, would need to be made [24].
A major limitation of this study was the short period of 
evaluation covering the rainy season but not the dry season. 
The study period (January to June 2014) only represents a 
six-month window where the evaluation was implemented. 
In addition, this period reflects early programme imple-
mentation. These limitations will likely underestimate the 
efficiency of the CHWs to react to incident cases as CHWs 
received continuous training and encouragement follow-
ing the implementation of the programme and follow-up 
is easier during the dry season [9]. However, programmes 
implementing reactive case detection strategies can learn 
from this experience. These results highlight the need for 
monitoring and evaluation shortly after implementation to 
identify operational challenges and their potential impact 
on programme performance and impact early on.
A strength of the RHC survey is that demographic 
data on the number of residents not in the home at the 
time of screening were collected. The reactive screen-
and-treat cascade used population-based survey data 
from the study area in Choma District. Information from 
Kalomo and Namwala Districts were not represented 
in these data; however, the people residing within the 
three districts are traditional subsistence farmers and 
are demographically similar. The model did not account 
for care seeking outside the government health facilities 
and assumed that all infected, symptomatic individuals 
sought care from government health facility, which may 
have overestimated the number of index cases detected 
through this system. However, the objective for creating 
the cascades was to provide estimates of the proportion 
of infected individuals identified and treated through 
reactive screen-and-treat and focal drug administration 
using multiple novel data sources.
Conclusion
With limited resources, coverage and diagnostic tools, 
reactive screen-and-treat will likely not be sufficient to 
achieve malaria elimination in this setting. However, high 
coverage with reactive focal drug administration could 
be efficient at decreasing the reservoir of infection and 
should be considered as an alternative strategy.
Fig. 8 Key areas impacting the efficiency of reactive screen-and-treat on index and and neighbouring households
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